Abstract

COVID-19: A REVIEW ON THE NOVEL CORONAVIRUS DISEASE

Bhavana Patil, Suraj Yadav*, Shrikesh Yadav*, Neha Yadav and Gopal Yadav

.

Abstract

The emergence and spread of new respiratory viruses in 2019 has raised global public health concerns. One of these is the 2019 novel coronavirus or SARS-CoV. There have been around 96,000 cases of coronavirus disease in 2019. The disease is mild in most people. In some, it can progress to pneumonia or acute respiratory distress syndrome. Many people are asymptomatic. Normal lab discoveries incorporate typical/low white cell counts with raised Cresponsiveprotein (CRP). The automated tomographic chest examine is generally unusual even in those with no manifestations or gentle sickness. Treatment is basically strong; job of antiviral specialists is yetto be set up. Counteraction involves home disconnection of suspected cases and those with gentleailments and severe contamination control measures at emergency clinics that incorporate contact and beadinsurances. The infection spreads quicker than its two precursors the SARS-CoV and Middle East respiratorydisorder Covid (MERS-CoV), yet has lower casualty. All over the world effect of this new pandemic is yet dubious.

Keywords: COVID-19, Pneumonia, SARS-Cov-2, MERS-Cov, RNA, 2019-n Cov.